PPT-Module 5: MONITORING, FOLLOW-UP, AND ADHERENCE SUPPORT FOR AGYW

ON ORAL PrEP Version December 2018 Initiation and clinical management of PrEP for AGYW Note for facilitator Initiation followup and maintenance of PrEP for AGYW should follow the same procedures as that of PrEP for adults . Doyle M. Cummings, PharmD, FCP, FCCP. Professor of Family Medicine and Public Health. East Carolina University, Brody School of Medicine. Greenville, North Carolina. . [Residency educators may . adapt and use . Reasons why patients do not adhere. Measuring adherence and non adherence. Improving adherence. Reasons for non-adherence: cognitive rational non-adherence. Adherence is all about being conscientious in following medical advice. . Oral . PrEP. in MSM. Division of Global HIV and TB, CDC, New Delhi, India. Timothy H. . Holtz . (CDC/DHAP / Thailand MOPH – US CDC Collaboration). and HPTN . 067/ADAPT Study . Team. MOSY08, IAS. , . Module 3: IMPORTANT FACTORS TO CONSIDER WHEN PROVIDING ORAL PrEP TO AGYW Version: August 2018 Outline of training Module 1: Introduction to oral PrEP PrEP: the basics What is combination prevention? Module 5: MONITORING, FOLLOW-UP, AND ADHERENCE SUPPORT FOR AGYW ON ORAL PrEP Version: August 2018 Initiation and clinical management of PrEP for AGYW Note for facilitator: Initiation, follow-up, and maintenance of PrEP for Module 4: ORAL PrEP PROVISION FOR AGYW: GETTING STARTED Version: August 2018 Outline of training Module 1: Introduction to oral PrEP PrEP: the basics What is combination prevention? How effective is oral PrEP? PrEP and Men: A man’s got to do, what a man’s got to do. Dr Saiqa Mullick, Wits RHI @ WitsRHI Share your thoughts on this presentation with #IAS2019 Context: It’s time for a conversation about male risk Julie Pulerwitz, ScD and Sanyukta Mathur, DrPH MHS . Girl uninterrupted: Evidence, implementation and agency. 24 July 2018. No conflicts of interest to disclose. Context. Should address the context in which AGYW live, to improve health & development outcomes. 1 City in Addis Ababa A Proposal on the CHBC Project Lisan Atnafe: CHBC Project Officer Anley Haile : MNCH project advisor February 2013 2 Acronyms AIDS Acquired Immunodeficiency Syndrome AMREF Afr AbstractBackground: The global burden is estimated to be 1% affecting over 65 million people it has profound physical, psychological and social impacts with a greater impact on a person’s quality EPF Position Paper March 2015 2 Adherence and Concordance EPF position paper , March 2015 Contents 1 Introduction ................................ ................................ .................... Version. : June 2019. Outline of training. Module 1: Introduction to oral PrEP. PrEP: the basics. What is combination prevention?. How effective is oral PrEP? . What are the differences among PrEP, PEP, and ART? . PrEP Counseling Center. What is Medication Adherence?. The World Health Organization defines medication adherence as the degree to which the person’s behavior corresponds with the agreed recommendations from a health care provider.. The Power of People: Community-based models to improve HIV outcomes. Komunyena Justine Tumusiime | Research Officer | PATH. What is your main question?. How do we improve the reach and uptake of HIV testing services (HTS) .